Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 116.92 USD -0.62%
Market Cap: 203.4B USD
Have any thoughts about
Abbott Laboratories?
Write Note

Abbott Laboratories
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abbott Laboratories
Long-Term Debt Peer Comparison

Comparables:
BDX
BSX
EW
SYK
ISRG

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Abbott Laboratories
NYSE:ABT
Long-Term Debt
$13.1B
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
13%
Becton Dickinson and Co
NYSE:BDX
Long-Term Debt
$18.1B
CAGR 3-Years
5%
CAGR 5-Years
0%
CAGR 10-Years
17%
Boston Scientific Corp
NYSE:BSX
Long-Term Debt
$9.2B
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
8%
Edwards Lifesciences Corp
NYSE:EW
Long-Term Debt
$597.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Stryker Corp
NYSE:SYK
Long-Term Debt
$13.3B
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
15%
Intuitive Surgical Inc
NASDAQ:ISRG
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Abbott Laboratories's Long-Term Debt?
Long-Term Debt
13.1B USD

Based on the financial report for Sep 30, 2024, Abbott Laboratories's Long-Term Debt amounts to 13.1B USD.

What is Abbott Laboratories's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
13%

Over the last year, the Long-Term Debt growth was -9%. The average annual Long-Term Debt growth rates for Abbott Laboratories have been -9% over the past three years , -6% over the past five years , and 13% over the past ten years .

Back to Top